Schiff Nutrition launches Valentine’s Day marketing campaign behind MegaRed
NEW YORK — Schiff Nutrition Group and M&C Saatchi NY on Tuesday launched a Valentine’s Day marketing campaign — “Whose Heart Do You Love” — in support of MegaRed krill oil supplements.
Through a custom Facebook application, MegaRed allows consumers to request a free product sample for their loved ones. As a bonus, the person requesting a sample on behalf of a friend also receives a free sample for themselves. As part of the effort, Schiff is making a $100,000 donation to the National Coalition for Women with Heart Disease.
The brand is relying heavily on peer-to-peer distribution through Facebook and an influencer component on Twitter where several celebrities are tweeting their support for the effort. Among those are Jennie Garth, Toni Braxton and Joy Bauer, all of whom have a personal interest in supporting heart health.
Blogger outreach is also being used to support the effort.
"Since Valentine’s Day is about celebrating who you love, we wanted to … to turn the sampling model on its head and expand the reach of our effort," stated Jennifer Steeves-Kiss, Schiff Nutrition chief marketing officer.
“Given the sampling effort is social in nature, so is the promotion behind it," noted Pierre Lipton, chief creative officer of M&C Saatchi NY.
Survey: 8-in-10 workout enthusiasts don’t have post-workout nutrition plan
ABBOTT PARK, Ill. — According to a national survey of fitness enthusiasts who exercise three or more times a week, 82% admitted to falling short when it comes to post-workout nutrition habits, Abbott announced Tuesday.
The results of the survey from Abbott’s EAS Sports Nutrition uncover a gap between Americans’ knowledge surrounding post-workout nutrition and their desire to improve their fitness routines and results.
Exercise and nutrition work in tandem. Evidence shows that obtaining proper nutrition at the right time is critical in maximizing the benefits of training regimens, including performance and improving lean muscle tone and reducing body fat. However, many fitness enthusiasts view post-workout nutrition as negatively impacting desired results:
- 36% don’t want to consume calories after a workout;
- 53% believe that eating protein after a workout will build undesired muscle; and
- 50% believe consuming carbohydrates post workout could yield less optimal results.
Half of fitness enthusiasts indicated that muscle fatigue and overall body soreness prevents them from exercising more frequently and amost all respondents (98%) said they were looking to improve how they felt post-workout in some way, including wanting more energy (42%) and less muscle soreness and fatigue (52%).
While 72% of fitness enthusiasts know that post-workout nutrition helps restore energy, only one in three recognized that it also helps to decrease muscle breakdown.
Titan Medical Enterprises shut down after violating drug, supplement good manufacturing practices
SILVER SPRING, Md. — A federal judge has ordered a California company and its owner to stop manufacturing and distributing drugs and dietary supplements in domestic commerce until their manufacturing operations comply with the Federal Food, Drug, and Cosmetic Act, the Food and Drug Administration reported Friday.
U.S. District Judge Otis Wright of the Central District of California signed the order on Dec. 11, 2012, against Titan Medical Enterprises and James McDaniel, Titan Medical’s owner and president. The order was entered in response to a complaint filed by the U.S. Department of Justice, on behalf of the FDA.
The court found that the company and McDaniel violated the Act by failing to follow current Good Manufacturing Practice for drugs and for dietary supplements. The court also found that the defendants violated federal law by distributing unapproved new drugs. Prior to entry of the court’s order, Titan Medical Enterprises manufactured and domestically distributed a variety of drugs and dietary supplements.
“The FDA continues to take strong enforcement actions against companies that fail to comply with federal drug and dietary supplement manufacturing regulations,” stated acting associate commissioner for regulatory affairs Melinda Plaisier. “The actions we are taking are necessary to make sure that the drugs and dietary supplements consumers purchase have been manufactured in compliance with cGMP."
Nine FDA inspections of Titan between 2001 and 2012 revealed that the company’s drugs were not manufactured and distributed in compliance with Drug cGMP. Violations included failure to establish an adequate written testing program to assess the stability of finished products and failure to establish and follow adequate laboratory controls.
The Dietary Supplement cGMP regulations went into effect in 2007 and became effective over the following three years based on company size. Titan’s compliance date was in 2010, and FDA inspections in 2010, 2011, and 2012 revealed that Titan violated the Dietary Supplement cGMP regulations by, among other things, failing to verify that a subset of finished dietary supplement batches met product specifications and failing to adequately confirm the identity of dietary supplement components.
Drug cGMP includes practices and systems required to be adopted in the manufacture and testing of pharmaceuticals. Drug cGMP outlines the aspects of production and testing that can impact the quality of a product.
Similarly, Dietary Supplement cGMP regulations require dietary supplement manufacturers to ensure quality in their dietary supplements by appropriately controlling all aspects of their processes and procedures to ensure a supplement meets minimal quality standards and is not adulterated by the presence of contaminants.